NO20053909L - Preventiv eller hjelpemiddel for intrauterin sen embryoniskutvikling eller svangerskapsforgiftning. - Google Patents

Preventiv eller hjelpemiddel for intrauterin sen embryoniskutvikling eller svangerskapsforgiftning.

Info

Publication number
NO20053909L
NO20053909L NO20053909A NO20053909A NO20053909L NO 20053909 L NO20053909 L NO 20053909L NO 20053909 A NO20053909 A NO 20053909A NO 20053909 A NO20053909 A NO 20053909A NO 20053909 L NO20053909 L NO 20053909L
Authority
NO
Norway
Prior art keywords
remarkable
gestational
poisoning
contraceptive
auxiliary
Prior art date
Application number
NO20053909A
Other languages
English (en)
Norwegian (no)
Inventor
Mamoru Kobayashi
Satoshi Murata
Yoshimi Tsukahara
Original Assignee
Kissei Pharmaceutical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Company filed Critical Kissei Pharmaceutical Company
Publication of NO20053909L publication Critical patent/NO20053909L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20053909A 2003-01-22 2005-08-22 Preventiv eller hjelpemiddel for intrauterin sen embryoniskutvikling eller svangerskapsforgiftning. NO20053909L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003012947 2003-01-22
PCT/JP2004/000355 WO2004064825A1 (ja) 2003-01-22 2004-01-19 子宮内胎児発育遅延又は妊娠中毒症の予防又は治療剤

Publications (1)

Publication Number Publication Date
NO20053909L true NO20053909L (no) 2005-08-22

Family

ID=32767347

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053909A NO20053909L (no) 2003-01-22 2005-08-22 Preventiv eller hjelpemiddel for intrauterin sen embryoniskutvikling eller svangerskapsforgiftning.

Country Status (14)

Country Link
US (1) US20060052458A1 (ko)
EP (1) EP1591115A4 (ko)
JP (1) JP4342516B2 (ko)
KR (1) KR101028496B1 (ko)
CN (1) CN100435787C (ko)
AU (1) AU2004206161B2 (ko)
BR (1) BRPI0406872A (ko)
CA (1) CA2513606A1 (ko)
MX (1) MXPA05007852A (ko)
NO (1) NO20053909L (ko)
NZ (1) NZ541332A (ko)
PL (1) PL377192A1 (ko)
RU (1) RU2337676C2 (ko)
WO (1) WO2004064825A1 (ko)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07316072A (ja) * 1994-05-24 1995-12-05 Green Cross Corp:The 妊娠中毒症治療剤
JPH08295635A (ja) * 1995-04-28 1996-11-12 Green Cross Corp:The 胎盤血流量改善剤
TW375604B (en) * 1996-02-19 1999-12-01 Kissei Pharmaceutical 3,4-di-substituting phenyl-ethanolamine-tetrahydronaphthyl carboxylic amide derivatives
JP4829418B2 (ja) * 2001-04-03 2011-12-07 キッセイ薬品工業株式会社 光学活性なハロヒドリン誘導体およびその使用方法

Also Published As

Publication number Publication date
EP1591115A1 (en) 2005-11-02
JPWO2004064825A1 (ja) 2006-05-18
CN100435787C (zh) 2008-11-26
JP4342516B2 (ja) 2009-10-14
AU2004206161B2 (en) 2008-07-03
US20060052458A1 (en) 2006-03-09
PL377192A1 (pl) 2006-01-23
BRPI0406872A (pt) 2006-01-03
CN1741798A (zh) 2006-03-01
MXPA05007852A (es) 2005-10-18
NZ541332A (en) 2007-10-26
CA2513606A1 (en) 2004-08-05
RU2005123303A (ru) 2006-01-27
AU2004206161A1 (en) 2004-08-05
EP1591115A4 (en) 2009-09-16
RU2337676C2 (ru) 2008-11-10
KR20050094861A (ko) 2005-09-28
WO2004064825A1 (ja) 2004-08-05
KR101028496B1 (ko) 2011-04-11

Similar Documents

Publication Publication Date Title
Kim et al. Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress
NO20064676L (no) Farmasoytiske salter av 3-0-(3'3'-dimetylsuccinyl)betulinsyre
US10501527B2 (en) Mast cell stabilizers for treatment of hypercytokinemia and viral infection
Qian et al. Neuroprotection by valproic acid in mouse models of permanent and transient focal cerebral ischemia
EA200601799A1 (ru) Гидразидсодержащие соединения - ингибиторы cftr и их применение
BRPI0819081A8 (pt) Formulação oftálmica aquosa, processo para preparar a mesma, e, método para inibir, tratar ou prevenir doenças oculares e doença ou condição relacionada, em um paciente em necessidade de tal tratamento
ATE400573T1 (de) 1h-imidazochinolinderivate als proteinkinaseinhibitoren
UA92348C2 (en) 17b-HSD1 AND STS INHIBITORS
JP2014510155A (ja) 抗ウイルス組み合わせ治療薬
JP2002540156A (ja) 抗ウイルス治療用チアジアゾリルウレアまたはチオウレア誘導体
MXPA05007857A (es) Moduladores derivados de indol de receptores nucleares de hormonas esteroideas.
BRPI0507375A (pt) derivados de 1h-tieno[2,3-c]pirazol úteis como inibidores de quinase
KR20180125552A (ko) 바이러스 감염을 치료하기 위한 티아졸리드 화합물
JP2016527307A5 (ko)
Park et al. Surfactin exhibits neuroprotective effects by inhibiting amyloid β-mediated microglial activation
KR20230107890A (ko) 정신병적 장애를 치료하기 위한 방법 및 조성물
DK1343472T3 (da) Thixotropisk næsespray
WO2013147585A1 (en) A composition having antiviral activity against flavivirus
NO20053909L (no) Preventiv eller hjelpemiddel for intrauterin sen embryoniskutvikling eller svangerskapsforgiftning.
TW200800977A (en) A new salt
SE0102887D0 (sv) New formulation
AU2002363874A1 (en) Use of desoxypeganine for treating clinical depression
US20110077270A1 (en) Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
CA2686833A1 (en) Compositions and methods for modulating inflammation using fluoroquinolones
Kumar et al. Possible role of NO modulators in protective effect of trazodone and citalopram (antidepressants) in acute immobilization stress in mice

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application